To Plan Your Visit To Our Campus
Please send an e-mail to firstname.lastname@example.org
You can plan your visit Monday to Friday between 9:30 AM to 5:30 PM.
Dr. Vikas, Vice President and Head of Operations at Jubilant Chemsys, is a creative, result oriented medicinal chemist with broad experience in Drug Discovery operations including Medicinal, Synthetic chemistry, biology and IP management with major contribution in the area of CNS therapeutics.
During his 20 years of industrial experience with Drug Discovery and services in India, he has lead the science, operations, IP strategies and has mainly contributed to the growth of two start-up companies which grew to the critical mass of 250 team.
At Zydus Research Center he worked on discovery of novel modulators for nuclear receptors.
During his association with Suven Life sciences, a start up Discovery group, he developed an integrated team for Drug Discovery and filed over 20 PCT applications in the area of CNS therapeutics in a short span of 4.5 years with a candidate in clinic for the mild to moderate cognition. The clinical candidate Masupirdine is in late Phase IIb trials for mild to moderate cognition.
As Head of Medicinal chemistry / CSO at Oxygen Healthcare Research, a Cambridge based start-up, he developed the effective and knowledge driven, customer centric teams. With the team of over 250 and annual growth rate of over 20 % in 5 years, Oxygen Bio was acquired by Piramal healthcare in 2011.
Working as a head of Operations at Jubilant Biosys since 2013. Has been awarded with multiple team achievements on business and scientific front.
A Pharmacist by training from Pune University, he completed his Masters and Ph.D. with Medicinal chemistry specialization from L. M. College of Pharmacy, Gujarat University.
2013 – till date - Jubilant Chemsys Limited & Jubilant Biosys Ltd – Sr. Vice President Global Operations.
Chemistry operations, Scientific operations and business development activities.
2006 – 2013 - Piramal Enterprises Limited – Chief Scientific Officer.
PDS offers valuable services in Discovery support for the early stage Discovery projects including HIt generation, lead optimization, early in-vitro safety / tox.
2002 – 2006 - Suven Life Sciences Limited – Deputy General Manager.
Worked mostly on GPCR targets for the therapy of Mild to moderate cognitive disorders, Alzheimer's, Obesity and Schizophrenia.
1999 – 2002 – Zydus Group - Research Scientist
Worked in the Department of Medicinal Chemistry